Journal of Vascular Surgery
Volume 50, Issue 4 , Pages 769-775 , October 2009

Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia

Presented at the 2009 Vascular Annual Meeting, Denver, Colo, June 11-14, 2009.

  • Andres Schanzer, MD

      Affiliations

    • University of Massachusetts Medical School, Worcester, Mass
    • Corresponding Author InformationReprint requests: Andres Schanzer, MD, Division of Vascular and Endovascular Surgery, University of Massachusetts Memorial Medical Center, 55 Lake Ave North, Worcester, MA 01655
    • ,
  • Philip P. Goodney, MD, MS

      Affiliations

    • Dartmouth-Hitchcock Medical Center, Lebanon, NH
    • ,
  • Youfu Li, MD, MPH

      Affiliations

    • University of Massachusetts Medical School, Worcester, Mass
    • ,
  • Mohammad Eslami, MD

      Affiliations

    • University of Massachusetts Medical School, Worcester, Mass
    • ,
  • Jack Cronenwett, MD

      Affiliations

    • Dartmouth-Hitchcock Medical Center, Lebanon, NH
    • ,
  • Louis Messina, MD

      Affiliations

    • University of Massachusetts Medical School, Worcester, Mass
    • ,
  • Michael S. Conte, MD

      Affiliations

    • University of California San Francisco, San Francisco, Calif
    • ,
  • Vascular Study Group of Northern New England

Received 4 May 2009 ,Accepted 28 May 2009.

References 

  1. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381–386
  2. McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis. 1991;87:119–128
  3. Murabito JM, Evans JC, Nieto K, Larson MG, Levy D, Wilson PW. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. 2002;143:961–965
  4. Howell MA, Colgan MP, Seeger RW, Ramsey DE, Sumner DS. Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity: a six-year follow-up study. J Vasc Surg. 1989;9:691–696discussion 696-7
  5. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925–1934
  6. Stoyioglou A, Jaff MR. Medical treatment of peripheral arterial disease: a comprehensive review. J Vasc Interv Radiol. 2004;15:1197–1207
  7. Steg PG, Bhatt DL, Wilson PW, D'Agostino R, Ohman EM, Röther J, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297:1197–1206
  8. Caro J, Migliaccio-Walle K, Ishak KJ, Proskorovsky I. The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database. BMC Cardiovasc Disord. 2005;5:14
  9. DeRubertis BG, Faries PL, McKinsey JF, Chaer RA, Pierce M, Karwowski J, et al. Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1000 percutaneous interventions. Ann Surg. 2007;246:415–422discussion 422-4
  10. Schanzer A, Mega J, Meadows J, Samson RH, Bandyk DF, Conte MS. Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg. 2008;48:1464–1471
  11. Conte MS, Lorenz TJ, Bandyk DF, Clowes AW, Moneta GL, Seely BL. Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure. Vasc Endovascular Surg. 2005;39:15–23
  12. Cronenwett JL, Likosky DS, Russell MT, Eldrup-Jorgensen J, Stanley AC, Nolan BW VSGNNE. A regional registry for quality assurance and improvement: the Vascular Study Group of Northern New England (VSGNNE). J Vasc Surg. 2007;46:1093–1101discussion 1101-2
  13. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg. 2006;43:742–751discussion 751
  14. Goodney PP, Likosky DS, Cronenwett JL Vascular Study Group of Northern New England. Factors associated with stroke or death after carotid endarterectomy in Northern New England. J Vasc Surg. 2008;48:1139–1145
  15. Abou-Zamzam AM, Lee RW, Moneta GL, Taylor LM, Porter JM. Functional outcome after infrainguinal bypass for limb salvage. J Vasc Surg. 1997;25:287–295discussion 295-7
  16. Nguyen LL, Moneta GL, Conte MS, Bandyk DF, Clowes AW, Seely BL PREVENT III Investigators. Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg. 2006;44:977–983discussion 983-4
  17. Thorsen H, McKenna S, Tennant A, Holstein P. Nottingham health profile scores predict the outcome and support aggressive revascularisation for critical ischaemia. Eur J Vasc Endovasc Surg. 2002;23:495–499
  18. Owens CD, Ho KJ, Kim S, Schanzer A, Lin J, Matros E, et al. Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification. J Vasc Surg. 2007;45:944–952
  19. Schanzer A, Hevelone N, Owens CD, Belkin M, Bandyk DF, Clowes AW, et al. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg. 2007;46:1180–1190discussion 1190
  20. Khuri SF, Daley J, Henderson W, Barbour G, Lowry P, Irvin G, et al. The National Veterans Administration Surgical Risk Study: risk adjustment for the comparative assessment of the quality of surgical care. J Am Coll Surg. 1995;180:519–531
  21. Khuri SF, Daley J, Henderson W, Hur K, Demakis J, Aust JB, et al. The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care (National VA Surgical Quality Improvement Program). Ann Surg. 1998;228:491–507
  22. O'Grady MA, Gitelson E, Swaby RF, Goldstein LJ, Sein E, Keeley P, et al. Development and implementation of a medical oncology quality improvement tool for a regional community oncology network: the Fox Chase Cancer Center Partners initiative. J Natl Compr Canc Netw. 2007;5:875–882
  23. Scott IA, Eyeson-Annan ML, Huxley SL, West MJ. Optimising care of acute myocardial infarction: results of a regional quality improvement project. J Qual Clin Pract. 2000;20:12–19
  24. Holman WL, Sansom M, Kiefe CI, Peterson ED, Hubbard SG, Delong JF, et al. Alabama coronary artery bypass grafting project: results from phase II of a statewide quality improvement initiative. Ann Surg. 2004;239:99–109
  25. O'Connor GT, Quinton HB, Kahn R, Robichaud P, Maddock J, Lever T, et al. Case-mix adjustment for evaluation of mortality in cystic fibrosis. Pediatr Pulmonol. 2002;33:99–105

 Competition of interest: none.

PII: S0741-5214(09)01191-4

doi: 10.1016/j.jvs.2009.05.055

Journal of Vascular Surgery
Volume 50, Issue 4 , Pages 769-775 , October 2009

Article Tools

* Image Usage & Resolution